Correlation Between Larimar Therapeutics and Ventyx Biosciences

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Larimar Therapeutics and Ventyx Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Larimar Therapeutics and Ventyx Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Larimar Therapeutics and Ventyx Biosciences, you can compare the effects of market volatilities on Larimar Therapeutics and Ventyx Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Larimar Therapeutics with a short position of Ventyx Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Larimar Therapeutics and Ventyx Biosciences.

Diversification Opportunities for Larimar Therapeutics and Ventyx Biosciences

0.1
  Correlation Coefficient

Average diversification

The 3 months correlation between Larimar and Ventyx is 0.1. Overlapping area represents the amount of risk that can be diversified away by holding Larimar Therapeutics and Ventyx Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ventyx Biosciences and Larimar Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Larimar Therapeutics are associated (or correlated) with Ventyx Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ventyx Biosciences has no effect on the direction of Larimar Therapeutics i.e., Larimar Therapeutics and Ventyx Biosciences go up and down completely randomly.

Pair Corralation between Larimar Therapeutics and Ventyx Biosciences

Given the investment horizon of 90 days Larimar Therapeutics is expected to generate 0.74 times more return on investment than Ventyx Biosciences. However, Larimar Therapeutics is 1.36 times less risky than Ventyx Biosciences. It trades about 0.01 of its potential returns per unit of risk. Ventyx Biosciences is currently generating about -0.03 per unit of risk. If you would invest  666.00  in Larimar Therapeutics on November 1, 2024 and sell it today you would lose (269.00) from holding Larimar Therapeutics or give up 40.39% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy99.8%
ValuesDaily Returns

Larimar Therapeutics  vs.  Ventyx Biosciences

 Performance 
       Timeline  
Larimar Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Larimar Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Even with weak performance in the last few months, the Stock's primary indicators remain relatively invariable which may send shares a bit higher in March 2025. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.
Ventyx Biosciences 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Ventyx Biosciences has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong basic indicators, Ventyx Biosciences is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Larimar Therapeutics and Ventyx Biosciences Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Larimar Therapeutics and Ventyx Biosciences

The main advantage of trading using opposite Larimar Therapeutics and Ventyx Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Larimar Therapeutics position performs unexpectedly, Ventyx Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ventyx Biosciences will offset losses from the drop in Ventyx Biosciences' long position.
The idea behind Larimar Therapeutics and Ventyx Biosciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .

Other Complementary Tools

Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Stocks Directory
Find actively traded stocks across global markets
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules